Relaxin proteins for use in the diagnosis, prevention or treatment of multiple sclerosis

摘要

The present invention relates to the use of one or more Relaxin proteins in methods for diagnoses and treatment of multiple sclerosis. The invention also provides compositions for use in diagnosing or treating multiple sclerosis as well as the methods themselves. Kits for carrying out the methods are also described.

主权项

1. A method of treating Multiple Sclerosis which comprises administering to a subject with Multiple Sclerosis a composition, wherein the composition is a pharmaceutical composition which comprises one or more Relaxins optionally together with one or more pharmaceutically acceptable carriers, excipients or diluents, wherein the Relaxins are selected from the group consisting of RLX1, RLX2, and a combination of RLX1 and RLX2.